Overview

Gastroesophageal Reflux Disease Devices Market is poised to value over CAGR of over 13.5% during the forecast period 2022 to 2028.

GERD is a disorder in which the lower esophageal sphincter (LES) relaxes or fails to function properly, allowing stomach liquids to reflux back into the oesophagus and cause heartburn. GERD is caused by a number of causes including smoking, hiatal hernia, abdominal obesity, and stress. GERD can cause esophagitis (swelling of the oesophagus), Barrett's oesophagus (barrel disease), and ulcers if left untreated. The severity of the condition is used to create treatment modules. In many countries, increased rates of abdominal obesity, as well as unhealthy diets and lifestyles, are linked to an increase in the prevalence of GERD. The demand for gastroesophageal reflux disease devices will rise as a result of this. The prevalence of gastroesophageal reflux is not gender-specific; nevertheless, males are more likely to develop problems as a result of the disease. GERD is more common as people get older, especially after the age of 40. The difficulties related with esophageal motility and a decreased production of saliva are linked to esophageal dysfunction in the older population. As a result, the growing senior population will continue to drive the market for gastroesophageal reflux disease devices. One of the primary factors driving market expansion is the high rate of obesity in the United States.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Gastroesophageal Reflux Disease Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Gastroesophageal Reflux Disease Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Gastroesophageal Reflux Disease Devices Market:
• Addex Pharmaceuticals Ltd.
• Aros Pharma ApS
• AstraZeneca Plc.
• C. R. Bard, Inc.
• Eisai Co., Ltd.
• EndoGastric Solutions, Inc.
• KARL STORZ SE & Co. KG.
• MediGus Ltd.
• Olympus Corporation
• PENTAX Medical (Global)
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• The Procter & Gamble Company
(Note: The list of the major players will be updated with the latest market scenario and trends)

Gastroesophageal Reflux Disease Devices Market Segmentation:
By Product Type
• Diagnostic Devices
• Esophagoscopes and Gastroscopes
• Fundoplication Devices
• Manometry System
• PH Monitoring System
• Radiofrequency Ablation Devices
• Sphincter Augmentation Devices
• Treatment Devices
• Ultrasonic Surgical Endostapler
By Procedure Type
• Diagnostic Procedures
• Fundoplication Procedures
• Magnetic Sphincter Augmentation
• Radiofrequency Thermal Ablation
By Device Type
• Bravo Reflux Testing System
• Digitrapper reflux testing system
• LINX Management System
• MUSE -Medigus Ultrasonic Surgical Endostapler
• Others
• Stretta Therapy
By Surgery Type
• Invasive
 o Linx Reflux Management
 o Medigus Ultrasonic Surgical Endostapler
• Non-invasive
 o Endocinch Endolumminal gastroplication
 o Endoscopic Plicator System
 o EsophyX
 o Plexiglas poly-methyl-methacrylate (PMMA) microspheres
 o Stretta
By Route of Administration
• Oral
• Parenteral
By Dosage Form
• Liquid
• Solid
By End Users
• Government
• Hospitals
• Medical Practitioners
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Gastroesophageal Reflux Disease Devices Market By Product Type, By Procedure Type, By Device Type, By Surgery Type, By Route of Administration, By Dosage Form, By End Users and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
  2.1 Research Data
      2.1.1 Secondary Data
            2.1.1.1 Key Data from Secondary Sources
      2.1.2 Primary Data
            2.1.2.1 Key Data from Primary Sources
  2.2 Market Size Estimation
  2.3 Market Breakdown and Data Triangulation
  2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Gastroesophageal Reflux Disease Devices Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Gastroesophageal Reflux Disease Devices Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Gastroesophageal Reflux Disease Devices Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Gastroesophageal Reflux Disease Devices Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Diagnostic Devices
  7.2. Esophagoscopes and Gastroscopes
  7.3. Fundoplication Devices
  7.4. Manometry System
  7.5. PH Monitoring System
  7.6. Radiofrequency Ablation Devices
  7.7. Sphincter Augmentation Devices
  7.8. Treatment Devices
  7.9. Ultrasonic Surgical Endostapler

8. Gastroesophageal Reflux Disease Devices Market, By Procedure Type Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Diagnostic Procedures
  8.2. Fundoplication Procedures
  8.3. Magnetic Sphincter Augmentation
  8.4. Radiofrequency Thermal Ablation

9. Gastroesophageal Reflux Disease Devices Market, By Device Type Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Bravo Reflux Testing System
  9.2. Digitrapper reflux testing system
  9.3. LINX Management System
  9.4. MUSE -Medigus Ultrasonic Surgical Endostapler
  9.5. Others
  9.6. Stretta Therapy

10. Gastroesophageal Reflux Disease Devices Market, By Surgery Type Historical Analysis and Forecast 2022-2028 (USD Million)  
   10.1. Invasive
         10.1.1. Linx Reflux Management
         10.1.2. Medigus Ultrasonic Surgical Endostapler
   10.2. Non-invasive
         10.2.1. Endocinch Endolumminal gastroplication
         10.2.2. Endoscopic Plicator System
         10.2.3. EsophyX
         10.2.4. Plexiglas poly-methyl-methacrylate (PMMA) microspheres
         10.2.5. Stretta
 
11. Gastroesophageal Reflux Disease Devices Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million)  
   11.1. Oral
   11.2. Parenteral

12. Gastroesophageal Reflux Disease Devices Market, By Dosage Form Historical Analysis and Forecast 2022-2028 (USD Million)  
   12.1. Liquid
   12.2. Solid

13. Gastroesophageal Reflux Disease Devices Market, By End Users Historical Analysis and Forecast 2022-2028 (USD Million)  
   13.1. Government
   13.2. Hospitals
   13.3. Medical Practitioners
   13.4. Others

14. North America Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. U.S.A
         14.2.2. Canada
         14.2.3. Mexico
   14.3. Market Size (USD Million) Forecast for North America 2022-2028

15. Latin America Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         15.2.1. Brazil
         15.2.2. Venezuela
         15.2.3. Argentina
         15.2.4. Rest of Latin America
   15.3. Market Size (USD Million) Forecast for Latin America 2022-2028

16. Europe Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         16.2.1. Germany
         16.2.2. U.K        
         16.2.3. France
         16.2.4. Italy
         16.2.5. Spain
         16.2.6. Russia
         16.2.7. Poland
         16.2.8. Rest of Europe
   16.3. Market Size (USD Million) Forecast for Europe 2022-2028

17. Asia Pacific Gastroesophageal Reflux Disease Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   17.1. Introduction
   17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         17.2.1. Japan
         17.2.2. China
         17.2.3. India
         17.2.4. Australia and New Zealand
         17.2.5. ASEAN
         17.2.6. Rest of Asia Pacific
   17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

18. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   18.1. Introduction
   18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         18.2.1. GCC
         18.2.2. Israel
         18.2.3. South Africa
         18.2.4. Rest of MEA
   18.3. Market Size (USD Million) Forecast for MEA 2022-2028

19. Market Share Analysis and Competitive Landscape  
   19.1. Global Landscape - Key Players, Revenue and Presence
   19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   19.3. Global Emerging Companies
   19.4. North America - Market Share Analysis and Key Regional Players
   19.5. Europe - Market Share Analysis and Key Regional Players
   19.6. Asia Pacific - Market Share Analysis and Key Regional Players
   19.7. Global Key Player - Growth Matrix

20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   20.1. Addex Pharmaceuticals Ltd.
         20.1.1. Company Overview
         20.1.2. Product Portfolio
         20.1.3. SWOT Analysis
         20.1.4. Financial Overview
         20.1.5. Strategic Overview
   20.2. Aros Pharma ApS
         20.2.1. Company Overview
         20.2.2. Product Portfolio
         20.2.3. SWOT Analysis
         20.2.4. Financial Overview
         20.2.5. Strategic Overview
   20.3. AstraZeneca Plc.
         20.3.1. Company Overview
         20.3.2. Product Portfolio
         20.3.3. SWOT Analysis
         20.3.4. Financial Overview
         20.3.5. Strategic Overview
   20.4. C. R. Bard, Inc.
         20.4.1. Company Overview
         20.4.2. Product Portfolio
         20.4.3. SWOT Analysis
         20.4.4. Financial Overview
         20.4.5. Strategic Overview
   20.5. Eisai Co., Ltd.
         20.5.1. Company Overview
         20.5.2. Product Portfolio
         20.5.3. SWOT Analysis
         20.5.4. Financial Overview
         20.5.5. Strategic Overview          
   20.6. EndoGastric Solutions, Inc.
         20.6.1. Company Overview
         20.6.2. Product Portfolio
         20.6.3. SWOT Analysis
         20.6.4. Financial Overview
         20.6.5. Strategic Overview      
   20.7. KARL STORZ SE & Co. KG.
         20.7.1. Company Overview
         20.7.2. Product Portfolio
         20.7.3. SWOT Analysis
         20.7.4. Financial Overview
         20.7.5. Strategic Overview
   20.8. MediGus Ltd.
         20.8.1. Company Overview
         20.8.2. Product Portfolio
         20.8.3. SWOT Analysis
         20.8.4. Financial Overview
         20.8.5. Strategic Overview
   20.9. Olympus Corporation
         20.9.1. Company Overview
         20.9.2. Product Portfolio
         20.9.3. SWOT Analysis
         20.9.4. Financial Overview
         20.9.5. Strategic Overview
   20.10.PENTAX Medical (Global)
         20.10.1. Company Overview
         20.10.2. Product Portfolio
         20.10.3. SWOT Analysis
         20.10.4. Financial Overview
         20.10.5. Strategic Overview
   20.11.Pfizer Inc.
         20.11.1. Company Overview
         20.11.2. Product Portfolio
         20.11.3. SWOT Analysis
         20.11.4. Financial Overview
         20.11.5. Strategic Overview
   20.12.Takeda Pharmaceutical Company Limited
         20.12.1. Company Overview
         20.12.2. Product Portfolio
         20.12.3. SWOT Analysis
         20.12.4. Financial Overview
         20.12.5. Strategic Overview
   20.13.The Procter & Gamble Company
         20.13.1. Company Overview
         20.13.2. Product Portfolio
         20.13.3. SWOT Analysis
         20.13.4. Financial Overview
         20.13.5. Strategic Overview

21. Pre and Post COVID-19 Impact
   21.1. Positive influence on the healthcare industry
   21.2. The financial disruption of the manufacturing sector
   21.3. Impact of COVID-19 on emerging companies
   21.4. Significant mandates in the healthcare regulations initiated by administrations
   21.5. The overall economic slowdown of the developing and developed nations

22. FutureWise SME Key Takeaway Points for Client

Tables

Figures